BioSpace News Archive

MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that it has commenced a proposed underwritten public offering of 3,750,000 shares of its common stock.

MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced that it will report first quarter 2018 financial and operating results after the U.S. financial markets close on Tuesday, May 8, 2018. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 4:30 p.m. ET (1:30 p.m. PT).

MyoKardia, Inc., a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced the appointment of Taylor C. Harris as Chief Financial Officer. Mr. Harris brings more than 20 years of finance and life science industry experience to MyoKardia and will lead the finance, accounting, information technology, facilities, corporate communications and investor relations functions.

Matthew E. Monaghan, chairman, president and chief executive officer and Kathy Leneghan, senior vice president and chief financial officer of Invacare Corporation (NYSE:IVC), will participate in the 3rd Annual Needham MedTech 1x1 Conference in Boston on Tuesday, August 7, 2018.

Legislation would strengthen the pipeline and stockpile of medical countermeasures vital to our nation’s safety and defense

Advisory Council launches its online consultations on how to move forward toward a national pharmacare

According to Grand View Research, the global legal cannabis industry was valued at USD 9.3 Billion in 2016 and is expected to grow at a CAGR of 34.6% during the forecast period from 2017 to 2025.

Nathan Falk, M.D., will be the first program director for the Florida State University College of Medicine Family Medicine Residency Program at Winter Haven Hospital.

The American Red Cross has elected to its National Board of Governors Steven H. Collis, Chairman, President and CEO of AmerisourceBergen Corporation.

The safety and efficacy of Essure have not changed [20-July-2018] WHIPPANY, N.J., July 20, 2018 /PRNewswire/ -- Bayer has made a business decision to voluntarily discontinue sales and distribution of the Essure ® System for Permanent Birth Control in the United States after December 31, 2018. This decision is based on a decline in U.S. sales of Essure